arrow
P

Peter Albers

german cancer research center
H指数:72
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term Results from the LEA Randomized Trial: Extended Versus Standard Lymph Node Dissection in Patients with Bladder Cancer Undergoing Radical Cystectomy

LEA随机试验的长期结果:接受根治性膀胱切除术的膀胱癌患者行扩大淋巴结清扫与标准淋巴结清扫的比较

2025-09-170
PRE
Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration

前列腺特异性膜抗原正电子发射断层扫描中仅淋巴结复发的前列腺癌,模板法与放射引导挽救性淋巴结清扫术的肿瘤学结局:多机构合作研究的结果

2025-08-180
PRE
Do We Need Early Detection of Grade Group 2 Prostate Cancer in a Screening Program for Young Men? Results from the PROBASE Screening Trial

我们是否需要在针对年轻男性的筛查计划中早期检测Gleason评分组2的前列腺癌?PROBASE筛查试验的结果

2025-07-100
OAAI
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging–targeted Biopsy in the PROBASE Trial

年轻男性前列腺癌检测:系统活检与磁共振成像靶向活检的比较分析——PROBASE试验

2025-06-020
OAAI
Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study

前列腺多参数磁共振成像在PROBASE研究中的特征分析:年轻且前列腺特异性抗原正常男性群体

2025-05-010
PRE
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trial

担心前列腺癌与风险认知在中年男性中的情况:PROBASE试验的结果

2025-03-050
OA
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic (vol 149, pg 913, 2022)

德国卓越中心在COVID-19大流行第一年中的癌症护理(vol 149, pg 913, 2022)

2025-01-180
OA
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial

风险调整后的前列腺癌筛查—利用PROBASE试验数据定义低风险组

2024-12-010
OAAI